SHIM
WVE icon

Stone House Investment Management’s Wave Life Sciences WVE Stock Holding History

Stone House Investment Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372 Sell
64
-29
-31% -$192 ﹤0.01% 1087
2026
Q1 		$674 Buy
+93
New +$1.21K ﹤0.01% 766

Other funds holding WVE

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Readystate Asset Management
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Stone House Investment Management's WVE Position: Q2 2026 in Review

Stone House Investment Management reduced its Wave Life Sciences (WVE) stake by 31% in Q2 2026, selling an estimated $192 and leaving 64 shares worth $372. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

Stone House Investment Management first reported a position in WVE in Q1 2026 and has held it in 2 quarters since. The position peaked at $674 in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Stone House Investment Management held 64 shares of Wave Life Sciences worth $372 as of Q2 2026.
  • Stone House Investment Management sold 29 Wave Life Sciences shares in Q2 2026, an estimated $192.
  • Wave Life Sciences made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #1087 holding.
  • Stone House Investment Management first reported a position in Wave Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Stone House Investment Management's Wave Life Sciences position peaked at $674 in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.